【招商证券】China Pharmaceutical & Healthcare - Expecting global funding recovery in the coming quarters.pdf

Expect Shengyi to enter Nvidia supply chain in 2024

Expect sustainable DPS growth onwards

Expecting inline 3Q revenue growth with upside coming from bottom line

China Property SectorNBS Nov data in line, expect new policy in BJ／SH to boost secondary market in Dec

Expect domestic business to rebound from 2025

China Property Sector: Property+ Weekly: Can we expect post-CNY recovery?

China Property Sector: NBS Nov data in line, expect new policy in BJ／SH to boost secondary market in Dec

Can Fiscal Consolidation Announcements Help Anchor Inflation Expectations?

–1H23 worse than expected on slow recovery; Maintain HOLD

China Pharmaceutical & Healthcare: Expecting global funding recovery in the coming quarters